5.90
price down icon5.90%   -0.37
pre-market  Pre-market:  5.59   -0.31   -5.25%
loading

Tenax Therapeutics Inc Stock (TENX) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
100.00%
-
6.6819 4.2348 2.4723 3.0789
Operating Expenses
16.98%
3.9083
3.3409 2.1174 1.2362 1.5395
Interest Income/Expense
269.68%
0.00796
0.00215 0.00534 0.00913 0.00735
Depreciation and Amortization
100.00%
-
0.00471 0.000969 0.001 0.000895
Operating Income/Loss
216.98%
-3.9083
3.3409 2.1174 1.2362 1.5395
Income/Loss From Continuing Operations Before Tax
17.77%
-3.7988
-3.2256 1.972 -1.1063 -1.4068
Income/Loss From Continuing Operations After Tax
17.77%
-3.7988
-3.2256 1.972 -1.1063 -1.4068
Net Income/Loss
17.77%
-3.7988
-3.2256 1.972 -1.1063 -1.4068
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
17.77%
-7.5977
-6.4512 - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$74.40
price up icon 0.53%
$22.96
price up icon 2.04%
$33.69
price down icon 0.33%
$357.50
price down icon 0.20%
$110.97
price down icon 5.14%
biotechnology ONC
$259.70
price up icon 0.47%
Cap:     |  Volume (24h):